Insider trades
Nicholas A. Saccomano, CEO of OnKure Therapeutics OKUR, has filed 0 purchases and 8 sales on the open market. Over the past 12 months that comes to a net sale of $1,253. The latest trade was on 09/21.
Nicholas A. Saccomano
President and CEO
- Company
- OnKure Therapeutics OKUR
- First filing
- 24/10/08
- Trades
- 16 trades
- Buys / sales
- 0 / 8
- 12-month net buying
- −$1,253
- Last trade
- 09/21
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market sale | 09/21 | 09/23 | 87 sh | $2.97 | $258.76 | −0.8% | |
| Open-market sale | 06/22 | 06/24 | 86 sh | $4.40 | $378.4 | −0.8% | |
| Open-market sale | 03/23 | 03/24 | 86 sh | $4.16 | $357.76 | −1.2% | |
| Open-market sale | 25/12/22 | 25/12/23 | 87 sh | $2.97 | $258.39 | −1.2% | |
| Open-market sale | 25/09/22 | 25/09/24 | 88 sh | $2.62 | $230.56 | −2.4% | |
| Open-market sale | 25/06/23 | 25/06/25 | 88 sh | $2.38 | $209.44 | −2.4% | |
OKUR | Open-market sale | 25/04/04–25/04/07 | 25/04/08 | 874 sh2 trades | $2.94avg. | $2,569.86 | −19.2% |